Predictors of medication adherence in patients with type 2 diabetes mellitus
- PMID: 23815104
- DOI: 10.1185/03007995.2013.821056
Predictors of medication adherence in patients with type 2 diabetes mellitus
Abstract
Objective: Medical professionals are often challenged by lack of patient compliance with pharmaceutical treatments. Research has shown that patients with diabetes have one of the lowest medication adherence rates at 65% to 85%. Some causes have been identified in the literature, but the influence of type of medication is unknown. This study assessed the impact of a broad range of factors on medication adherence and persistence among adult patients with type 2 diabetes mellitus.
Methods: Patients were selected from the Truven Health MarketScan Research Databases of healthcare administrative claims (2009 through 2012), assigned to mutually exclusive cohorts based on initiation of saxagliptin (a dipeptidyl peptidase-4 [DPP-4] inhibitor), or a glucagon-like peptide 1 (GLP-1) receptor agonist (daily or twice daily formulation), sulfonylurea (SU), or thiazolidinedione (TZD), and screened for continuous enrollment 1 year before and after drug initiation. Adherence and persistence were measured using proportion of days covered and time to discontinuation, respectively. Multivariate models were used to examine the impact of study drug and demographic and clinical factors.
Results: Overall, 45.1% of patients were adherent with their study drug over the 1 year follow-up period. Adherence was higher among patients who were male, older, or residing in non-Southern states. Adherence was better with mail-order use and lower levels of cost sharing. Patients taking a GLP-1 (OR = 0.40, 95% CI = 0.37, 0.42), SU (OR = 0.49, 95% CI = 0.46, 0.52), or TZD (OR = 0.54, 95% CI = 0.51, 0.57) were less likely to be adherent compared with those taking saxagliptin. Results were mixed regarding the impact of comorbidities and polypharmacy on medication adherence. Influencing factors may be the type of comorbidity, overall health level, number of drugs, and complexity of the drug regimen.
Key limitations: Adherence was measured using data for prescriptions dispensed and it is not known whether patients actually took the medications, hence adherence may be overestimated. Whether patients who discontinued the study drugs switched to other diabetes medications or discontinued treatment completely was not measured.
Conclusion: Identified risk factors can guide medical professionals in their attempts to increase the likelihood of patient adherence to drug treatment regimens.
Similar articles
-
Retrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitus.Adv Ther. 2014 Dec;31(12):1287-305. doi: 10.1007/s12325-014-0171-3. Epub 2014 Dec 12. Adv Ther. 2014. PMID: 25504156 Free PMC article.
-
Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register.Diabetes Obes Metab. 2016 Oct;18(10):990-8. doi: 10.1111/dom.12704. Epub 2016 Jul 19. Diabetes Obes Metab. 2016. PMID: 27282621
-
Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study.Diabetes Obes Metab. 2014 Dec;16(12):1247-56. doi: 10.1111/dom.12379. Epub 2014 Sep 10. Diabetes Obes Metab. 2014. PMID: 25109825 Free PMC article.
-
Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.IDrugs. 2008 Dec;11(12):906-17. IDrugs. 2008. PMID: 19051153 Review.
-
Saxagliptin plus metformin combination in patients with type 2 diabetes and renal impairment.Expert Opin Drug Metab Toxicol. 2012 Mar;8(3):383-94. doi: 10.1517/17425255.2012.658771. Epub 2012 Feb 8. Expert Opin Drug Metab Toxicol. 2012. PMID: 22313172 Review.
Cited by
-
Treatment Adherence and Quality of Life Among Elderly Patients With Diabetes Mellitus Registered in the Community.Cureus. 2024 Apr 25;16(4):e58986. doi: 10.7759/cureus.58986. eCollection 2024 Apr. Cureus. 2024. PMID: 38800199 Free PMC article.
-
Frequency of missed doses and its effects on the regulation of glucose levels in patients with type 2 diabetes: A retrospective analysis.Medicine (Baltimore). 2024 Apr 12;103(15):e37711. doi: 10.1097/MD.0000000000037711. Medicine (Baltimore). 2024. PMID: 38608082 Free PMC article.
-
The Impact of Clinical Pharmacist Diabetes Education on Medication Adherence in Patients with Type 2 Diabetes Mellitus: An Interventional Study from Khartoum, Sudan.J Pers Med. 2024 Jan 8;14(1):74. doi: 10.3390/jpm14010074. J Pers Med. 2024. PMID: 38248775 Free PMC article.
-
Control Level of Type 2 Diabetes Mellitus in the Elderly Is Associated with Polypharmacy, Accompanied Comorbidities, and Various Increased Risks According to the Beers Criteria.Diagnostics (Basel). 2023 Nov 13;13(22):3433. doi: 10.3390/diagnostics13223433. Diagnostics (Basel). 2023. PMID: 37998569 Free PMC article.
-
Prevalence and reasons influenced medication non-adherence among diabetes patients: A mixed-method study.J Diabetes Metab Disord. 2022 Sep 13;21(2):1669-1678. doi: 10.1007/s40200-022-01118-9. eCollection 2022 Dec. J Diabetes Metab Disord. 2022. PMID: 36404839 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous